Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polidocanol vs Hypertonic Glucose for Reticular Veins
NCT02054325Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Botucatu
- Start
- Sep 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of 10XB101 in reticular veins (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina de Botucatu. Primary endpoint: Mean Percent Reticular Vein Disappearance at 2 months. Started Sep 2012; status: completed.
02
Drugs
10XB101
03
Conditions
reticular veins
Beyond the preview
Go deeper on NCT02054325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054325.